Ovsynch synchronization and fixed-time insemination in goats.
This study assessed the efficacy of an Ovsynch protocol (vs. the classical cronolone containing vaginal sponge+eCG treatment) to generate fixed-time insemination in goats during the breeding season. Each regimen was applied to 24 Boer goat does. Onset and duration of estrus were determined with an aproned male and follicular development was monitored by ultrasonography. Ovulation and quality of the corpora lutea were established from progesterone concentrations. In 10-11 goats per group, LH concentrations were determined throughout the preovulatory period. Does were inseminated at pre-determined times (16 h after the second GnRH injection and 43 h after sponge removal). Estrus was identified in 96% of the Ovsynch-treated goats (at 49 h after prostaglandin injection) and in 100% of the goats synchronized with sponges (at 37 h after sponge removal). Low progesterone concentrations at the time of AI were observed in 21/24 and 24/24 goats synchronized by Ovsynch and sponges, respectively. Synchronization of the LH surge was tighter following Ovsynch compared to sponge treatment. Kidding rates (at 58 and 46% in the Ovsynch and sponge groups, respectively) and prolificacy (at 1.86 and 1.83 in the Ovsynch- and sponge-treated goats) were similar for both groups, as were the number of ovulations (2.9 and 3.3) and the proportion of does with premature corpus luteum regression (29 and 17%). When excluding does with premature luteal regression and those with low progesterone levels when receiving prostaglandins, kidding rate reached 87.5% (14/16) after Ovsynch. During the breeding season, the Ovsynch protocol may thus be an useful alternative to the sponge-eCG treatment.
Holtz
W
W
Institute for Animal Husbandry and Genetics, Goettingen University, Albrecht-Thaerweg 3, 37075 Goettingen, Germany. wholtz@gwdg.de
Sohnrey
B
B
Gerland
M
M
Driancourt
M-A
MA
D000818:Animals; D001947:Breeding / Q000379:methods; D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D003274:Contraceptive Devices, Female / Q000662:veterinary; D030762:Estrous Cycle / Q000097:blood / Q000187:drug effects; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D003425:Flurogestone Acetate / Q000008:administration & dosage*; D006041:Goats; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary*; D007986:Luteinizing Hormone / Q000097:blood; D011247:Pregnancy; D018873:Pregnancy Rate; D013997:Time Factors
D006063:Chorionic Gonadotropin; D007986:Luteinizing Hormone; D003425:Flurogestone Acetate